Drugs / NNC 0128-0000-2011
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01272206 | Jan → Mar 2011 | hemophilia A, hemophilia B | Novo Nordisk A/S | Completed | No outcome recorded |
| Phase 1 | NCT01288391 | Jan → Jul 2011 | hemophilia A, hemophilia B | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NNC 0128-0000-2011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01272206 ↗ |
| Route | Intravenous | “Administered as one single i.v. (intravenous) injection” NCT01272206 ↗ |